IVX (IVX) Fair Value & Analysis
Healthcare · Market cap A$4.7M
Fair value as of: Jun 26, 2026
From 3 valuation models · updated 6 days ago
Fair value updated Jun 26, 2026 — revised from A$0.3800 to A$0.1120 (−70.5%) since Jun 24, 2026. Share price −30.4% over the past month.
Price vs Fair Value (12 months)
12‑month range A$0.0400 – A$0.1813 · fair‑value band A$0.0640 – A$0.1760 · the A$0.0400 price screens below the A$0.1120 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
IVX (IVX) currently trades at A$0.0400, while our model-based Fair Value estimate is A$0.1120 — implying the stock looks roughly 180.0% undervalued today. We read business quality at 28/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Trailing-twelve-month revenue stands at A$3.0K. Fundamentals as of Jun 26, 2026
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
IVX reported revenue of A$0 in FY2025 versus A$2.3M in FY2021. Reported net income was −A$8.8M in FY2025.
Is IVX fairly valued? → Check now
Similar stocks
6 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| 1276 1276 | HK$57.85 | HK$29.84 | -48% |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥47.01 | ¥26.59 | -43% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,782 | ₹915.92 | -49% |
| Zoetis Inc Z1TS34 | R$26.19 | R$26.01 | -1% |
| Hansoh Pharmaceutical Group 3692 | HK$29.58 | HK$18.75 | -37% |
| Divi's Laboratories Limited DIVISLAB | ₹6,788 | ₹2,035 | -70% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is IVX (IVX) undervalued?
What is the fair value of IVX?
What is the quality score of IVX?
What is the revenue of IVX (IVX)?
What is the net profit margin of IVX?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.